Michael Cuffe Sells 1,500 Shares of HCA Healthcare (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. This trade represents a 4.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

HCA Healthcare Stock Down 2.3%

NYSE:HCA opened at $501.89 on Friday. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $527.55. The stock has a market cap of $114.53 billion, a P/E ratio of 17.68, a PEG ratio of 1.58 and a beta of 1.36. The business’s 50-day moving average price is $479.97 and its two-hundred day moving average price is $442.08.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Institutional Trading of HCA Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Brighton Jones LLC purchased a new position in HCA Healthcare in the 4th quarter worth about $1,021,000. NewEdge Advisors LLC boosted its holdings in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its stake in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the last quarter. Ameritas Advisory Services LLC bought a new stake in shares of HCA Healthcare in the second quarter worth $153,000. Finally, Wealthcare Advisory Partners LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $218,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several research reports. The Goldman Sachs Group lifted their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target for the company. in a research report on Monday, December 15th. Deutsche Bank Aktiengesellschaft boosted their target price on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $521.55.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.